February 26, 2018 / 7:53 AM / 6 months ago

BRIEF-Destiny Pharma Says FDA Accepted INDA For Xf-73​

Feb 26 (Reuters) - Destiny Pharma Plc:

* ‍ANNOUNCES THAT US FDA ACCEPTED AN INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR COMPANY’S LEAD CLINICAL DRUG CANDIDATE, XF-73​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below